Electronic healthcare records (EHR)
Incidence of phimosis and paraphimosis in patients treated with SGLT2 inhibitors
United Kingdom
EU PAS number:
EUPAS106882
First published:
22/03/2024
StudyFinalised
A Non-Interventional Multi-Country Post-Authorisation Safety Study (PASS) to Assess the Incidence of Serious Infections & Malignancies in Systemic Lupus Erythematosus (SLE) Patients Exposed to Anifrolumab (SIMA PASS)
Denmark
France
Germany
Spain
EU PAS number:
EUPAS105690
First published:
02/07/2024
StudyPlanned
Non-interventional study of patients with Netherton Syndrome to characterise the natural history of disease (Natural history of Netherton Syndrome)
Austria
China
France
Germany
Italy
Japan
Netherlands
United Kingdom
United States
EU PAS number:
EUPAS103733
First published:
11/02/2025
StudyOngoing
mRNA-1273-P901, Real-World Study of the Effectiveness of Moderna COVID-19 Vaccine
United States
EU PAS number:
EUPAS106670
First published:
30/07/2024
StudyOngoing
Observational, multicentre, prospective, real-world post-authorization safety study describing the achievement of nintedanib-associated DIArrhoea control after 12 weeks of follow-up in patients with idiopathic puLmonary FIBrosis (IPF) and progressive pulmonary fibrosis (other than IPF) in Spain: the DIALFIB study
Spain
EU PAS number:
EUPAS106524
First published:
03/07/2025
StudyOngoing
Pregnancy protection and pregnancies in women of reproductive age on ACE-Inhibitors (ACEi), Angiotensin Receptor Blockers (ARB), statins or anti-diabetic medications: an observational study in primary care.
United Kingdom
EU PAS number:
EUPAS106500
First published:
23/04/2024
StudyPlanned
Patient characteristics and treatment pathways in patients with COPD initiated on ICS/LABA/LAMA and LABA/LAMA treatment
United Kingdom
EU PAS number:
EUPAS106491
First published:
23/02/2024
StudyPlanned
DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS106436
First published:
30/01/2025
StudyFinalised
DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)
Estonia
France
Germany
United Kingdom
EU PAS number:
EUPAS106052
First published:
25/09/2024
StudyFinalised
DARWIN EU® Drug utilization study of prescription opioids
Belgium
Estonia
France
Germany
Netherlands
Spain
EU PAS number:
EUPAS105641
First published:
13/06/2025
StudyFinalised